EVALUATION METABOLIC SYNDROME IN POLYCYSTIC OVARIAN SYNDROME IN REPRODUCTIVE AGE GROUP WOMEN

Abstract

Background: The disorder can be morphological (polycystic ovaries) or predominantly biochemical (hyperandrogenemia). Hyperandrogenism, a clinical hallmark of PCOS, can cause inhibition of follicular development, microcysts in the ovaries, anovulation, and menstrual changes

Objectives: To study the risk factors for developing metabolic syndrome in PCOS.

Material and Methods: This is Prospective study, total 100 patients, department of obs and Gynae,  women of reproductive agegroup (15-45yrs) attending OPD at Darbhanga medical college and Hospital Laheriasarai, Bihar. Conclusion: This study helps in recognition of this high-risk group and aid in the enforcement of preventive strategies including therapeutic lifestyle modificationsand risk factor management. This will have a promising impact on women’s health and will prevent or delay the outset of varyingcardiometabolic complications in PCOS.

Keywords: PCOS, metabolic syndrome